Tags : Loxo Oncology


Eli Lilly to Acquire Loxo Oncology for $8B

Shots: Eli Lily acquires Loxo Oncology, in all stock transaction for $8B. Loxo to receive $235/share in cash making $8B as total deal value, including premium based on its last day closing share price value The focus of the acquisition is to utilize Loxo’s approved oncology portfolio for patients with genomically defined cancers. The acquisition […]Read More